Recent Finacing
Recent Raise
CinDome Pharma is a Cincinnati-based biopharma developing deudomperidone (CIN-102), a deuterated domperidone for chronic gastroparesis, currently in Phase 2 trials after safety and gastric-emptying signals.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors